US medical device maker Medtronic Inc has said it agreed to buy Dublin-based Covidien Plc for $42.9bn (€31.6bn) and shift its executive headquarters to Ireland in the latest move by US firms to harvest lower corporate tax rates abroad.

The world’s biggest maker of heart-rhythm devices, said fourth-quarter sales of pacemakers and defibrillators rose, surprising analysts.